← Back to Search

Behavioural Intervention

Meditation for Cancer Survivors

N/A

Recruiting

Led By Richard T Lee

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: ≥ 18 years

No previous training in mind-body relaxation techniques exceeding 3 hours or regular practice within the past 12 months

Must not have

Previous serious illnesses affecting neurological functioning such as strokes, heart attacks, Parkinson disease, etc

Active cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing different meditation techniques to see which one is most effective in helping cancer survivors relax and reduce stress and anxiety. Meditation involves methods like breathing, focusing attention, and mindfulness to improve the overall

Who is the study for?

This trial is for cancer survivors who are looking to reduce stress and anxiety through meditation. Participants will try one of four meditation practices to see which helps them relax the most.

What is being tested?

The study tests four types of meditation: breathing, focused attention, mindfulness, and a combination of all three. The goal is to determine which method best promotes relaxation and improves quality of life in cancer survivors.

What are the potential side effects?

Meditation therapy is generally considered safe with minimal risks. Some participants may experience increased anxiety or discomfort during practice, but serious side effects are rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I haven't practiced mind-body relaxation for more than 3 hours or regularly in the last year.

Select...

I can fluently speak and understand English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not had serious illnesses like strokes or heart disease affecting my brain.

Select...

My cancer is currently active.

Select...

I am currently pregnant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence rate

Retention rate

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Group I: Arm IV (combined meditation)Experimental Treatment3 Interventions

Patients learn breathing, focused attention, and mindfulness combined meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Group II: Arm III (mindfulness only meditation)Experimental Treatment3 Interventions

Patients learn mindfulness only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Group III: Arm I (focused attention only meditation)Experimental Treatment3 Interventions

Patients learn focused attention only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Group IV: Arm I (breathing only meditation)Experimental Treatment3 Interventions

Patients learn breathing only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Meditation Therapy

2018

N/A

~50

Biospecimen Collection

2004

Completed Phase 3

~2020